Invivyd expands COVID-19 study, develops measles antibody candidate
Go back to Invivyd expands COVID-19 study, develops measles antibody candidate| (NASDAQ: IVVD) | Delayed: 0.77 -0.04 (4.94%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.81 | 52 Week High | $ | |||
| Open | $0.82 | 52 Week Low | $ | |||
| Day High | $0.88 | P/E | N/A | |||
| Day Low | $0.73 | EPS | $ | |||
| Volume | 8,327,516 | |||||

